PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial.
Zehua WuYuanzhe ZhangYi ChengJianxia LiFangqian LiChao WangLishuo ShiGe QinWeixiang ZhanYue CaiXiaoyu XieJiayu LingHuabin HuJianwei ZhangYanhong DengPublished in: Med (New York, N.Y.) (2024)
Funded by the National Natural Science Foundation of China (81974369) and the program of Guangdong Provincial Clinical Research Center for Digestive Diseases (2020B1111170004).